Brain tumor sleep study halted early
NCT ID NCT03868943
Summary
This study tested whether a drug called solriamfetol, which promotes wakefulness, could help adults with stable brain tumors (gliomas) feel less sleepy and fatigued, and improve their memory and quality of life. The main goal was to check the drug's safety at different doses. The trial was terminated early after enrolling only two participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.